Aquestive Therapeutics (AQST) Cash & Equivalents (2017 - 2026)
Aquestive Therapeutics' Cash & Equivalents was $98.49 million in Q2 2026, up 62.7% from $60.54 million a year earlier but down 11.1% from the prior quarter.
Powered by 
Analysis
Aquestive Therapeutics (AQST) Cash & Equivalents (2017 - 2026) Analysis & Trends
At the end of FY2025, Cash & Equivalents at Aquestive Therapeutics came in at $121.17 million, up 69.4% from FY2024.
- Cash & Equivalents shows a five-year compound annual growth rate of 30.7% (FY2020 to FY2025).
- In earlier years, Cash & Equivalents was $71.55 million in FY2024 (+199.7%), $23.87 million in FY2023 (-12.5%), $27.27 million in FY2022 (-2.7%) and $28.02 million in FY2021 (-11.9%).
- Quarterly Cash & Equivalents has moved between $14.74 million (Q1 2022) and $129.06 million (Q3 2025) over five years.
- Compared with a year earlier, Cash & Equivalents has increased for four straight quarters, with growth averaging 76.4% over the last eight quarters.
- The best year-over-year quarter for Cash & Equivalents over five years was Q2 2024 (growth of 300.6%); the worst was Q2 2022 (a decline of 48.3%).
- Per Business Quant data, AQST's Cash & Equivalents in the three quarters before Q2 2026 was $110.73 million (Q1 2026), $121.17 million (Q4 2025) and $129.06 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Aquestive Therapeutics | 571.08 Mn | 111.62 Mn | 9.80 Mn | 98.49 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 98.49 Mn |
| Mar 31, 2026 | 110.73 Mn |
| Dec 31, 2025 | 121.17 Mn |
| Sep 30, 2025 | 129.06 Mn |
| Jun 30, 2025 | 60.54 Mn |
| Mar 31, 2025 | 68.66 Mn |
| Dec 31, 2024 | 71.55 Mn |
| Sep 30, 2024 | 77.89 Mn |
| Jun 30, 2024 | 89.87 Mn |
| Mar 31, 2024 | 95.20 Mn |
| Dec 31, 2023 | 23.87 Mn |
| Sep 30, 2023 | 24.92 Mn |
| Jun 30, 2023 | 22.44 Mn |
| Mar 31, 2023 | 26.88 Mn |
| Dec 31, 2022 | 27.27 Mn |
| Sep 30, 2022 | 18.65 Mn |
| Jun 30, 2022 | 17.70 Mn |
| Mar 31, 2022 | 14.74 Mn |
| Dec 31, 2021 | 28.02 Mn |
| Sep 30, 2021 | 31.16 Mn |
API Access
Aquestive Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=AQST&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "AQST", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=AQST&period=max&api_key=YOUR_API_KEY");
const data = await res.json();